- Home
- FBIO vs EPSN Comparison
FBIO vs EPSN Comparison
Compare FBIO & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- EPSN
- Stock Information
- Founded
- FBIO 2006
- EPSN 2005
- Country
- FBIO United States
- EPSN Canada
- Employees
- FBIO N/A
- EPSN N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- EPSN Oil & Gas Production
- Sector
- FBIO Health Care
- EPSN Energy
- Exchange
- FBIO Nasdaq
- EPSN Nasdaq
- Market Cap
- FBIO 88.7M
- EPSN 106.1M
- IPO Year
- FBIO N/A
- EPSN N/A
- Fundamental
- Price
- FBIO $2.75
- EPSN $4.79
- Analyst Decision
- FBIO Strong Buy
- EPSN
- Analyst Count
- FBIO 2
- EPSN 0
- Target Price
- FBIO $16.50
- EPSN N/A
- AVG Volume (30 Days)
- FBIO 341.4K
- EPSN 171.9K
- Earning Date
- FBIO 11-14-2025
- EPSN 11-05-2025
- Dividend Yield
- FBIO N/A
- EPSN 5.25%
- EPS Growth
- FBIO N/A
- EPSN 11.33
- EPS
- FBIO N/A
- EPSN 0.27
- Revenue
- FBIO $62,303,000.00
- EPSN $45,709,605.00
- Revenue This Year
- FBIO $31.85
- EPSN $41.35
- Revenue Next Year
- FBIO $44.43
- EPSN N/A
- P/E Ratio
- FBIO N/A
- EPSN $17.80
- Revenue Growth
- FBIO N/A
- EPSN 46.76
- 52 Week Low
- FBIO $1.33
- EPSN $4.36
- 52 Week High
- FBIO $4.20
- EPSN $8.50
- Technical
- Relative Strength Index (RSI)
- FBIO 55.02
- EPSN 47.53
- Support Level
- FBIO $2.40
- EPSN $4.59
- Resistance Level
- FBIO $2.76
- EPSN $4.85
- Average True Range (ATR)
- FBIO 0.16
- EPSN 0.22
- MACD
- FBIO 0.03
- EPSN 0.01
- Stochastic Oscillator
- FBIO 94.59
- EPSN 56.43
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.